Age and Gender Issues in the Management of Pericardial Diseases

  • Massimo Imazio
Chapter

Abstract

Management of pericardial diseases should consider specific issues related to the age of patients (essentially dosing issues) and gender (especially considering specific physiological conditions such as pregnancy and lactation) [1].

Keywords

Familial Mediterranean Fever Pericardial Effusion Pericardial Disease Paediatric Emergency Department Paediatric Setting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Authors/Task Force Members, Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristić AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921–64.Google Scholar
  2. 2.
    Geggel RL. Conditions leading to pediatric cardiology consultation in a tertiary academic hospital pediatrics. Pediatrics. 2004;114:409–17.CrossRefGoogle Scholar
  3. 3.
    Shakti D, Hehn R, Gauvreau K, Sundel RP, Newburger JW. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J Am Heart Assoc. 2014;3, e001483.Google Scholar
  4. 4.
    Raatikka M, Pelkonem PM, Karjalainen J, Jokinen E. Recurrent pericariditis in children and adolescents. J Am Coll Cardiol. 2003;42:759–64.CrossRefPubMedGoogle Scholar
  5. 5.
    Imazio M, Brucato A, Pluymaekers N, Breda L, Calabri G, Cantarini L, Cimaz R, Colimodio F, Corona F, Cumetti D, Di Blasi Lo Cuccio C, Gattorno M, Insalaco A, Limongelli G, Russo MG, Valenti A, Finkelstein Y, Martini A. Recurrent pericarditis in children and adolescents: etiology, presentation, therapies, and outcomes. A multicenter cohort study. J Cardiovasc Med. 2016; in press.Google Scholar
  6. 6.
    Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009;60:264–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Finetti M, Insalaco A, Cantarini L, Meini A, Breda L, Alessio M, D’Alessandro M, Picco P, Martini A, Gattorno M. Long term efficacy of interleukin-1 receptor antagonist (anakinra) in steroid dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425–31.CrossRefPubMedGoogle Scholar
  8. 8.
    Scardapane A, Brucato A, Chiarelli F, Breda L. Efficacy of interleukin-1beta receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol. 2013;34:1989–91.CrossRefPubMedGoogle Scholar
  9. 9.
    Gaspari S, Marsili M, Imazio M, Brucato A. New insights in the pathogenesis and therapy of idiopathic recurrent pericarditis in children. Clin Exp Rheumatol. 2013;31:788–94.PubMedGoogle Scholar
  10. 10.
    Ristić AD, Seferović PM, Ljubić A, Jovanović I, Ristić G, Pankuweit S, Ostojić M, Maisch B. Pericardial disease in pregnancy. Herz. 2003;28:209–15.CrossRefPubMedGoogle Scholar
  11. 11.
    Brucato A, Imazio M, Curri S, Palmieri G, Trinchero R. Medical treatment of pericarditis during pregnancy. Int J Cardiol. 2010;144:413–4.CrossRefPubMedGoogle Scholar
  12. 12.
    Imazio M, Brucato A. Management of pericarditis in women. Womens Health (Lond Engl). 2012;8:341–8.CrossRefGoogle Scholar
  13. 13.
    Imazio M, Brucato A, Rampello S, Armellino F, Trinchero R, Spodick DH, Adler Y. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010;11:557–62.CrossRefGoogle Scholar
  14. 14.
    Østensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, Doria A, Rai R, Meroni P, Cetin I, Derksen R, Branch W, Motta M, Gordon C, Ruiz-Irastorza G, Spinillo A, Friedman D, Cimaz R, Czeizel A, Piette JC, Cervera R, Levy RA, Clementi M, De Carolis S, Petri M, Shoenfeld Y, Faden D, Valesini G, Tincani A. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Henderson JT, Whitlock EP, O’Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:695–703.CrossRefPubMedGoogle Scholar
  16. 16.
    Gill SK, O’Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol. 2009;104:1541–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003;62:916–9.PubMedCentralCrossRefPubMedGoogle Scholar
  18. 18.
    Ben-Chetrit E, Scherrmann JM, Levy M. Colchicine in breast milk of patients with familial Mediterranean fever. Arthritis Rheum. 1996;39:1213–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Ehrenfeld M, Brzezinski A, Levy M, Eliakim M. Fertility and obstetric history in patients with familial Mediterranean fever on long-term colchicine therapy. Br J Obstet Gynaecol. 1987;94:1186–91.CrossRefPubMedGoogle Scholar
  20. 20.
    Pasina L, Brucato AL, Falcone C, Cucchi E, Bresciani A, Sottocorno M, Taddei GC, Casati M, Franchi C, Djade CD, Nobili A. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31:283–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Massimo Imazio
    • 1
  1. 1.Cardiology DepartmentMaria Vittoria Hospital and Department of Public Health and Pediatrics University of TorinoTorinoItaly

Personalised recommendations